(P207) Timing of Anti-GAD Antibodies and C-Peptide Tests

Research shows that Anti-GAD antibodies and C-peptide levels can be used as preliminary screening tests for differentiation of type 1 and type 2 diabetes . C-peptide levels can even be beneficial in identifying clients with type 2 diabetes and marked insulin‐deficiency. This poster will outline a case study that examines a 34-year-old female with obesity. The client’s blood work revealed a HbA1C of 7% and elevated albumin creatinine ratio of 7.1. Her fasting blood glucose results were mainly at target with the post prandial results being above target at times.

Discussion: Early recognition of the type of diabetes and proper management can make a difference in outcomes. Coordinated care and understanding the clients’ needs and acting on them are crucial to managing diabetes.